News provided by google

Post-cancer, Lisa Ray back to life - Hindustan Times


NDTV.com

Post-cancer, Lisa Ray back to life
Hindustan Times
"My disease, multiple myeloma, is in remission. We don't take the attitude that it is ever gone completely, but we monitor regularly and now I'm leading a ...
Revelling in royaltyNational Post

all 31 news articles »

Onyx Says Carfilzomib Slows Cancer Development in Hard-to-Treat Myeloma - Bloomberg



The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief ... - Business Wire (press release)


The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief ...
Business Wire (press release)
(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced the appointment of Walter Capone to Chief Operating Officer. ...

and more »

Celgene Corp. sees increase in revenue fueled by sales of Revlimid cancer drug - The Star-Ledger - NJ.com


The Star-Ledger - NJ.com

Celgene Corp. sees increase in revenue fueled by sales of Revlimid cancer drug
The Star-Ledger - NJ.com
BUSINESS: The company makes powerful cancer medicines, including Revlimid, which is one of the leading treatments for multiple myeloma, a blood cancer. ...
Celgene 2Q Profit Up 8.8%; Again Boosts 2010 ViewWall Street Journal
Q2 Revenues Rise at CelgeneZacks.com
Celgene earnings top expectations, shares jumpFOXBusiness

all 37 news articles »

Pat's Place: All Multiple Myeloma Patients Need An Advocate - The Myeloma Beacon


Pat's Place: All Multiple Myeloma Patients Need An Advocate
The Myeloma Beacon
Having a primary caregiver is important, but each multiple myeloma patient also needs an advocate—someone to help fight day-to-day battles with the health ...


The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief ... - Earthtimes (press release)


Earthtimes (press release)

The Multiple Myeloma Research Foundation (MMRF) Names Walter Capone Chief ...
Earthtimes (press release)
(Business Wire) The Multiple Myeloma Research Foundation (MMRF) today announced the appointment of Walter Capone to Chief Operating Officer. ...


Double Stem Cell Transplant With Low-Dose And High-Dose Melphalan Is An ... - The Myeloma Beacon


Double Stem Cell Transplant With Low-Dose And High-Dose Melphalan Is An ...
The Myeloma Beacon
Melphalan (Alkeran) is a chemotherapeutic drug that is frequently used in combination with stem cell transplants to treat younger multiple myeloma patients. ...


Benefit at wine bar is personal - Detroit Free Press


Benefit at wine bar is personal
Detroit Free Press
Strouse's late wife, Bonnie, succumbed to multiple myeloma in 2008, and Simecek's mother, Sharon Simecek of Milan, has been diagnosed with Alzheimer's ...

and more »

Cancer institute celebrates opening of expansion - Arkansas News


Cancer institute celebrates opening of expansion
Arkansas News
Beebe said the cancer institute's multiple myeloma program is No. 1 in the nation, and its other cancer programs are world-class. ...

and more »

Google Apps offers product for governments - San Francisco Chronicle


Google Apps offers product for governments
San Francisco Chronicle
The study found 24 percent of patients with multiple myeloma had at least a partial response, and their improvement lasted a median of 7.4 months, ...

and more »